About Us
  • Wells Health Group is a boutique health policy consulting and government relations firm based in Washington, DC.  
  • WHG specializes in healthcare consulting for pharmaceutical, medical device, specialty pharmacy, medical management, physician services, M&A advisors and innovators to help maximize stakeholder value.​
  • Our innovative approach to health policy consulting is based on a core set of essential strategy analytics and focused reimbursement pathways.
  • We provide clients a systematic and targeted engagement by working sequentially through interconnected groups of analytics to verify solid sustainable health policy strategies and reimbursement pathway tactics.
Why Our Experience Matters - We deliver focused executable strategies to help maximize stakeholder value based on real-life healthcare industry experiences
The U.S. Healthcare delivery system, unlike any other industry, is based on the platform of a complex private and public sector third-party payer system and has become ever increasingly problematic to navigate. 
  • The health policy decision-making process is complicated.
  • The reimbursement methodologies are convoluted.
  • The funding is not keeping pace with healthcare demand and innovation.
WHG helps pharmaceutical, medical device, specialty pharmacy, medical management, physician services, M&A advisors and innovators circumnavigate the multifaceted process of how the Administration, Congress and Federal Agencies shape health policy and implement change.
Health Policy Challenges
  • Government agency and reimbursement processes are not always intuitive and can lead to uncertainties and misconceptions.
  • FDA approval and FDA clearance allows for commercialization. It does not mean that a product is covered or eligible for reimbursement by Medicare, Medicaid, or commercial insurance.
  • FDA approved indications for use and FDA product coding can result in potential downstream consequences.  These FDA controlled regulations affect site of care utilization, benefit category determination, coverage criteria and payment.
  • Establishing a new HCPCS/CPT code does not equate to CMS coverage or payment, as these reimbursement steps are separate CMS processes.
  • The cost of innovation is not an inevitable part of payment calculation processes.​
WHG Consulting Services - Our innovative approach to health policy consulting is based on a core set of essential strategy analytics and focused reimbursement pathways.
​Health Policy
  • Strategy Analytics - Comprehensive Medicare, Medicaid and commercial insurance reimbursement pathway analysis. Guidance through all seven-reimbursement steps - from diagnosis, treatment plan, site of care, and benefit category to coding, coverage and payment.
  • Reimbursement Pathways – We identify the foundation of reimbursement hurdles and opportunities. We prioritize executable milestones to support policy strategies and help maximize stakeholder value.
Government Relations
  • WHG helps clients solve problems navigating the Government’s complex healthcare policy structure and multi-layered decision-making to develop effective government relations strategies.
  • WHG understands the nuances of how the Administration, Congress and Federal Agencies interact in shaping healthcare policy. Our healthcare industry knowledge is critical to effective strategy implementation.​
M&A Advisors
  • One of the most critical and challenging analytics of healthcare M&A is evaluating the health policy strategy component.​
  • The U.S. Healthcare delivery system, unlike any other industry, is based on the economics of a complex private and public sector third-party payer system and has become ever increasingly problematic to navigate. 
  • We help clients evaluate a transaction’s potential to maximize stakeholder value based on real-life experiences.